| Patient | Martin Luther King |
|---|---|
| Date of birth | 1990-01-15 |
| Identifiers | MRN HR-ML001-SYN; SSN (made up) 000-01-4058 |
| Document date | 2026-06-02 |
| Author | Cornelius Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eight-week review of depression, sleep, smoking and home blood pressure. [S]
Dr. King returns three weeks after his preventive visit. The nurse telephone call planned two weeks after starting sertraline did not reach him because he was travelling; he took sertraline 50 mg daily, with nausea for a few days only. He has had six therapy sessions and keeps a fixed rising time; he now sleeps about six hours. He stopped smoking on his quit date two weeks ago, using varenicline, and has mild nausea after the morning dose and vivid dreams, but no change in mood; cravings come late at night when he writes. He has kept his day off on four of the past six weeks. His home blood pressure readings over seven days averaged 136/86. He has had no thoughts of harming himself. [S]
| Element | Detail |
|---|---|
| Sertraline | 50 mg for five weeks; early nausea only |
| Missed call | Two-week nurse call did not reach him |
| Smoking | Stopped two weeks ago on varenicline; night cravings |
| Home blood pressure | Seven-day average 136/86 |
| Sleep | About six hours |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Less tired |
| Respiratory | Negative | Morning cough easing since he stopped smoking |
| Gastrointestinal | Positive | Mild nausea after the morning varenicline dose |
| Neurological | Negative | No headaches |
| Psychiatric | Positive | Mood better; vivid dreams; PHQ-9 11; no suicidal ideation |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg tablet, one by mouth once daily for 3 days, then twice daily for 4 days | once daily for 3 days, then twice daily for 4 days, after food | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Varenicline 1 mg tablet, one by mouth twice daily after food | twice daily after food | Oral route | 2026-05-19 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for one week | once daily in the morning | Oral route | 2026-04-20 to 2026-04-27 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 2026-04-27 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-02 | Body height | 170 | cm | S |
| 2026-06-02 | Body weight | 84.6 | kg | S |
| 2026-06-02 | Body mass index (BMI) [Ratio] | 29.3 | kg/m2 | S |
| 2026-06-02 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-06-02 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-06-02 | Heart rate | 76 | /min | S |
| 2026-06-02 | Respiratory rate | 14 | /min | S |
| 2026-06-02 | Body temperature | 36.7 | Cel | S |
| 2026-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 11 | {score} | S | ||
| 2026-06-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S | ||
| 2026-06-02 | Albumin/Creatinine [Mass Ratio] in Urine | 8 | mg/g | Below 30 | Normal | S |
Vital signs recorded on 2026-06-02; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Blood pressure 134/86, pulse 76; weight 84.6 kg, BMI 29.3 |
| Eyes | Fundi: no hypertensive retinopathy |
| Cardiovascular | Regular rhythm; no murmur or added sounds |
| Psychiatric | Brighter; reactive affect; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Exhaustion, broken sleep and low mood for about two months, under sustained threats and a punishing schedule, after an admission for exhaustion and a respiratory infection six months ago; cause not established at intake: a depressive disorder, an adjustment disorder, PTSD, an insomnia disorder, thyroid disease and anemia to be assessed; psychiatry consultation requested | resolved | confirmed | R53.83 | S — Synthetic presenting problem anchored to his documented admission for exhaustion and the threats against him; superseded by the diagnoses at the second visit. |
| Major depressive disorder, single episode, moderate (DSM-5-TR), arising under chronic threat, surveillance and overwork; no suicidal ideation; PTSD not present on screening and interview | active | confirmed | F32.1 | S — Synthetic modern diagnosis made at the psychiatry consultation, linked to his documented exhaustion and threats and to biographers' accounts of depression (R); not a claim that he was so diagnosed. |
| Insomnia disorder (DSM-5-TR), comorbid with depression: trouble falling and staying asleep at least four nights a week for over three months, with short sleep from late-night work and travel | active | confirmed | G47.00 | S — Synthetic modern diagnosis made at the psychiatry consultation. |
| Nicotine dependence, cigarettes: about a pack a day since his twenties, smoked out of public view | active | confirmed | F17.210 | S — Synthetic modern problem anchored to the documented account of his heavy, hidden smoking. |
| Elevated blood pressure readings in the clinic (138/88 mmHg) without a diagnosis of hypertension; home monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding; superseded by the diagnosis at the six-week visit. |
| Healed stab wound of the left chest, repaired by thoracotomy seven years ago; occasional aching along the scar with coughing and in cold weather, without exertional or ischemic features | active | confirmed | Z87.828 | S — Synthetic modern problem anchored to his documented stabbing and chest surgery in 1958. |
| Stage 1 hypertension (2017 ACC/AHA), confirmed by home readings averaging 136/86 mmHg; no end-organ damage (normal ECG, urine albumin, kidney function and fundi); low estimated 10-year risk; lifestyle treatment | active | confirmed | I10 | S — Synthetic modern diagnosis made at the eight-week visit; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 11, from 17 at intake |
| Survey | GAD-7 | Every 4 to 8 weeks during treatment | Completed today | 7, from 11 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation; PHQ-9 item 9 scored 0; no mood change on varenicline. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Deferred | Protocol deviation: the nurse telephone call due two weeks after sertraline started did not reach him because he was travelling, and no second attempt was made. His tolerability and mood were checked at the preventive visit three weeks after starting, when he reported only brief nausea and no suicidal thoughts, so no harm resulted. Corrective action: calls are now booked through his office's travel schedule, with a second attempt within two days |
| Medication safety | Varenicline neuropsychiatric and adverse-effect review | Weekly by quitline for the first weeks, and every visit | Completed today | Mild nausea and vivid dreams; no agitation, low mood or unusual thoughts |
| Self-management | Smoking status after the quit date | Every visit | Completed today | Smoke-free for two weeks by his report |
| Survey | Insomnia Severity Index and sleep diary | Every visit during CBT for insomnia | Completed today | Insomnia Severity Index 13; about six hours a night (score in the notes; no LOINC code used) |
| Examination | Out-of-office blood pressure to confirm the diagnosis | Before diagnosis and when treatment changes | Completed today | Seven-day home average 136/86 on a validated arm monitor |
| Examination | Office blood pressure, weight and BMI | Every visit | Completed today | 134/86 mmHg; weight 84.6 kg, BMI 29.3 |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Completed today | 8 mg/g, normal |
| Laboratory | Basic metabolic panel, TSH, glucose or A1c, and lipids at diagnosis | At diagnosis, then yearly | Up to date | Drawn at intake eight weeks ago: all normal except LDL 142 mg/dL |
| Imaging | 12-lead ECG at diagnosis | Baseline | Up to date | Normal at intake |
| Examination | Fundoscopic examination | At diagnosis, then yearly | Completed today | No hypertensive retinopathy |
| Survey | 10-year cardiovascular risk | Yearly | Completed today | Low by the PREVENT equations; the Pooled Cohort Equations do not apply under 40 |
| Self-management | Sustainable work plan: a day off each week, two speeches a day at most, sleep window kept | Every visit | Completed today | Day off kept on four of six weeks; two speeches a day at most on most days |
Goal progress:
Guideline basis: Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016); 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); Development and Validation of the American Heart Association's PREVENT Equations (2024)
Follow-up: Home blood pressure for a week before the next visit. Review in six weeks. Next scheduled visit 2026-07-14: fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan. [S]